Asklepios BioPharmaceutical Inc., ("AskBio") is a biotechnology company engaged in the development and delivery of novel protein and cellular based therapies through design of proprietary Biological Nano ParticlesTM ("BNP").
The Biological Nano Particle is a cutting-edge technology for the sustained and systemic delivery of therapeutic proteins. Once administered to the patient, the BNPsTM utilize the patient's own cells as both protein bioreactor and pump.
AskBio commenced operations in 2003, and is a privately-held clinical-stage biotech based in the Research Triangle, North Carolina. BNPsTM are capable of addressing a platform of therapies and are currently in clinical validation.